{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/06/23/3315699/0/en/Press-Release-Sanofi-s-Cenrifki-tolebrutinib-approved-in-the-EU-as-the-first-disability-targeting-medicine-for-secondary-progressive-multiple-sclerosis-without-relapses.html", "message": "News view counter 811102 successfully enlarged"}